Oxford, United Kingdom

Oliver John Gibson

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Oxehealth Limited. Active years: 2021.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Oliver John Gibson: Innovator in Vital Signs Monitoring

Introduction

Oliver John Gibson is a notable inventor based in Oxford, GB. He has made significant contributions to the field of health monitoring through his innovative patent. His work focuses on the development of methods and apparatuses that enhance the monitoring of vital signs in both humans and animals.

Latest Patents

Gibson holds a patent for a "Method and apparatus for monitoring of a human or animal subject." This invention utilizes video imaging to analyze a subject's vital signs, such as heart rate and breathing rate. The method includes determining whether the subject is still or moving, ensuring accurate readings. The system can detect movement manually or automatically, and it only displays vital signs when the subject is still and no extraneous regions are detected in the image.

Career Highlights

Gibson is associated with Oxehealth Limited, a company dedicated to advancing health monitoring technologies. His work at Oxehealth has positioned him as a key player in the development of innovative health solutions.

Collaborations

Some of his notable coworkers include Nicholas Dunkley Hutchinson and Peter Richard Dodds. Their collaboration has likely contributed to the success of their projects and innovations in the field.

Conclusion

Oliver John Gibson's contributions to vital signs monitoring represent a significant advancement in health technology. His innovative approach and dedication to improving monitoring methods have the potential to enhance patient care and safety.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…